NUCLEAR LAMINA, OVARIAN AGE AND MEDICAL ASSISTANCE TO PROCREATION
NCT03686111 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2018-09-26
Summary
The nuclear lamina (LN) consists of a network of proteins interposed between the chromatin and the internal nucleic membrane, to which it is closely associated. LN consists essentially of lamins encoded by the LMNA (Lamines A / C), LMNB1 and LMNB2 genes (BI, B2, B3 lamins). Malfunctions of the A / C-type laminates causing the production of a toxic isoform called progerin are directly responsible for various serious pathologies such as Progeria Hutchingson-Gilford. This rare disease is characterized by accelerated pathological aging. Moreover, it is known that progerin is produced in the absence of any mutation of the gene LMNA is involved in the physiological aging of tissus.
The ovarian reserve of a woman is a parameter that changes with age. Although this progressive loss is inevitable in the course of life, the kinetics of this ovarian exhaustion appear variable according to the women, sometimes leading to an accelerated loss causing a discordance between the female age and the ovarian age. But ovarian age becomes a major prognostic parameter to be taken into account during any attempt at medical assistance to procreation (AMP) and is often incriminated in the failures of MPAs. There are currently few markers to predict the quality of ovarian response of women to ovarian stimulation, let alone the quality of the oocytes retrieved. However, their quality directly influences their ability to give an evolving embryo and therefore a pregnancy Our team has previously shown that type B laminates are involved in human spermiogenesis, and highlighted the human B3 isoform. These very encouraging results obtained on human spermatogenesis, have prompted us to also look at the potential interest of the exploration of the nuclear lamina within the human ovary.
The aim of this project is therefore to continue the exploration of the nuclear lamina and its potential role on the quality of human gametes, by studying the follicular ovarian cells surrounding the oocyte. These cells express A / C type lamins and sometime progerin Investigators want to conduct a prospective pilot study in a cohort of 40 women in MPA, aged between 20 and 42 years. The main objective is to compare the levels of expression of the A / C, B and progerin laminae in the follicular cells of 2 groups of women: a group of infertile patients managed to induce ovulation in order to Intraconjugal AMP and a group of women managed to induce ovulation to give their oocytes. For this purpose, investigators will analyze the expression of the A / C and B lamins in RT-PCR, the localization of the lamins and progerin in immunofluorescence, and will look for quantitative variations in the production of A / C and / or progerin lamins by western- blot, depending on the age of the patients.
This pilot study will allow investigators to characterize for the first time the LN of human follicular cells. They should highlight variations in the expression and / or localization of lamins and possibly progerin in patients tested according to their age and / or ovarian reserve. The team preliminary results showed that this track deserves to be explored. This is an excellent opportunity to bring new insights into the understanding of the mechanisms responsible for alteration of ovarian reserve in women and the prognosis of MPA attempts.
Finally, this approach could serve as a basis for a larger, multicenter study. These markers could represent new diagnostic markers to be taken into account to evaluate the chances of pregnancy of each woman in AMP.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
oocytes collect
After stimulation, an echo-guided oocyte puncture is performed under anesthesia
Sponsors & Collaborators
-
Assistance Publique Hopitaux De Marseille
lead OTHER
Principal Investigators
-
Emilie GARRIDO · Assistance Publique Hopitaux De Marseille
Eligibility
- Min Age
- 20 Years
- Max Age
- 42 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-01
- Primary Completion
- 2019-12-01
- Completion
- 2020-12-01
Countries
- France
Study Locations
More Related Trials
-
Single and Double DNA Strand Breaks in Males With Unexplained Infertility Attending Fertility Treatment
NCT05846256 ·Status: UNKNOWN
-
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
NCT04142112 ·Status: UNKNOWN ·Phase: NA
-
Identification and Characterization of the Methylation Abnormalities on Whole Genome Among Infertile Men
NCT01239186 ·Status: COMPLETED
-
NT-NOA - Novel Treatment of Some Men With Non-Obstructive Azoospermia
NCT06706414 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
The Value of HBA in the Evaluation of Idiopathic Infertility
NCT01683435 ·Status: COMPLETED ·Phase: NA
-
Chromosomal and Morphological Structure of Mature and Immature Male Germ Cells and Recognition of IL-18 in Testicular Tissue of Azoospermic Men
NCT00544089 ·Status: COMPLETED
-
Is the Lack of Prior Exposure to Sperm Antigens Associated With Worse Neonatal and Maternal Outcomes?
NCT04852237 ·Status: COMPLETED
-
Testicular Proteins for Sperm Retrieval Prediction Protein1, Testis-Expressed Gene 101, and Lectin Galactoside-binding Protein in Predicting Surgical Sperm Retrieval in Men With Non-Obstructive Azoospermia
NCT06154954 ·Status: RECRUITING
-
Timing of Oocyte Retrieval and Micro Testicular Sperm Extraction
NCT07268235 ·Status: COMPLETED
-
Study of the ZyMōt Sperm Selection Method and Its Effect on Embryo Ploidy.
NCT06384794 ·Status: RECRUITING ·Phase: NA
-
Automated Intracytoplasmic Sperm Injection (ICSIA)
NCT05633316 ·Status: UNKNOWN ·Phase: NA
-
Study of Spermatogenesis Suppression With DMAU Alone or With LNG Versus Placebo Alone in Normal Men
NCT03455075 ·Status: COMPLETED ·Phase: PHASE2
-
Sperm DNA Damage to Intracytoplasmic Sperm Injection Outcome
NCT03129243 ·Status: COMPLETED
-
Male Hormonal Contraceptive Development-ACY-5
NCT00161447 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Preimplantation Genetic Testing for Aneuploidy (PGT-A) in Couples With Non-obstructive Azoospermia (NOA)
NCT06566599 ·Status: ACTIVE_NOT_RECRUITING
-
Impact of DNA Fragmentation in Sperm on Pregnancy Outcome After Intra-uterine Insemination in a Spontaneous Cycle
NCT03319654 ·Status: COMPLETED ·Phase: NA
-
Functional Development and Clinical Validation of a Diagnostic Tool Based on Artificial Intelligence for the Assessment of Sperm Quality and the Selection of the Optimal In Vitro Fertilisation (IVF) Treatment
NCT07185984 ·Status: NOT_YET_RECRUITING
-
Contraception in Normal and Subnormal Men
NCT00167141 ·Status: TERMINATED ·Phase: PHASE2
-
DNA Fragmentation - Effect on Pregnancy Rate
NCT05397314 ·Status: COMPLETED ·Phase: NA
-
Seminal Levels of PGK2 and ACRV1 as Predictors of Micro-TESE Results in NOA
NCT06307639 ·Status: NOT_YET_RECRUITING
-
Impact of Sperm DNA Integrity on In Vitro Cycles
NCT01232465 ·Status: COMPLETED
-
Molecular Markers of Human Sperm Function
NCT00767611 ·Status: WITHDRAWN
-
Impact of Sperm DNA Integrity on Artificial Reproductive Treatment (ART)
NCT00875095 ·Status: TERMINATED
-
Home Semen Analysis Tests As a Screening Tool for Fertility Patients
NCT06188936 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Modern Analyses of the Semen in Evaluating Male Fertility and Treatment Options of Male Infertility
NCT02932865 ·Status: COMPLETED